More long silence from Elizabeth. Sorry. It’s not that I haven’t been thinking about Indonesia. It’s that I’ve been focusing on just one thing: the quality of the medicines in the Indonesian market. With wonderful colleagues like Amalia Hasnida, Yusi Anggriani and Sari Dewi, we’ve been trying to figure out why people make low quality medicines, and why people sell and take them. It’s a complicated story, especially in Indonesia, but Tempo’s cover story this week highlights an important part…